Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: Mapping diagnostic and therapeutic opportunities
Author:
Open Access
- 1 December 2017
- journal article
- review article
- Published by Elsevier in Genes & Diseases
- Vol. 4 (4) , 196-203
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and BeyondBioMed Research International, 2013
- Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survivalIUBMB Life, 2012
- Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?Cell, 2012
- Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal responseJournal of Molecular and Cellular Cardiology, 2010
- Oxidative Stress in the Progression of Alzheimer Disease in the Frontal CortexJournal of Neuropathology & Experimental Neurology, 2010
- Glucose‐6‐phosphate dehydrogenase‐deficient mice have increased renal oxidative stress and increased albuminuriaThe FASEB Journal, 2009
- Glucose-6-phosphate Dehydrogenase Deficiency and Malaria: Cytochemical Detection of Heterozygous G6PD Deficiency in WomenJournal of Histochemistry & Cytochemistry, 2009
- Oxidant–antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of diseaseNeurochemistry International, 2008
- Identification and validation of housekeeping genes as internal control for gene expression in an intravenous LPS inflammation model in chickensVeterinary Immunology and Immunopathology, 2008
- Glucose-6-phosphate dehydrogenase activity and NADPH/NADP+ ratio in liver and pancreas are dependent on the severity of hyperglycemia in ratLife Sciences, 2006